Meeting Details

The 27th AGM of Wockhardt Limited was held on Monday, 10th August 2026 at 10:30 a.m. IST through Video Conferencing/Other Audio Visual Means (VC/OAVM). The meeting was conducted in compliance with the Companies Act, 2013 and relevant MCA circulars. The record date for determining shareholder eligibility was 3rd August 2026.

Attendance

The meeting was attended by all Directors, the Chief Financial Officer, Company Secretary, representative of Statutory Auditors, and the Secretarial Auditor & Scrutinizer. A total of 187 members attended the AGM as per the Attendance Register. Dr. Habil Khorakiwala, Founder Chairman, chaired the meeting.

Proposed Resolutions and Implications

The following 10 resolutions were proposed for shareholder approval:

Ordinary Business:

1. Adoption of Audited Standalone and Consolidated Financial Statements for FY ended 31st March 2026

2. Re-appointment of Ms. Zahabiya Khorakiwala (DIN: 00102689) as Director retiring by rotation

Special Business:

3. Ratification of remuneration of ₹3,85,000 plus taxes to Kirit Mehta & Co. LLP as Cost Auditors for FY 2026-27

4. Revision in remuneration of Dr. Habil Khorakiwala (DIN: 00045608) as Executive Chairman for 3 years from March 1, 2027 to February 28, 2030, not exceeding ₹10 Crore per annum initially and ₹15 Crore per annum overall ceiling

5. Approval of Material Related Party Transactions with Wockhardt Bio AG for aggregate value up to ₹1,000 Crore

6. Approval of Material Related Party Transactions between Wockhardt Bio AG and CP Pharmaceuticals Limited for aggregate value up to ₹550 Crore

7. Approval of Material Related Party Transactions between Wockhardt Bio AG and Wockhardt UK Limited for aggregate value up to ₹550 Crore

8. Approval for raising additional capital not exceeding ₹3,000 Crore through QIP or other offerings

9. Appointment of Ms. Zahabiya Khorakiwala as Executive Co-chairperson of Wockhardt Bio AG at remuneration of USD 250,000 per annum

10. Modification in the Objects of Qualified Institutions Placement

Voting Process

The remote e-voting facility was provided through NSDL's platform from Friday, 7th August 2026 (09:00 a.m. IST) till Sunday, 9th August 2026 (05:00 p.m. IST). Shareholders who hadn't voted remotely could vote during the AGM through the e-voting platform, which remained open for 15 minutes after the meeting concluded.

Key Voting Outcomes

Overall Participation:

  • Total shareholders on record date: 172,841
  • Total votes cast: 107,406,822 shares (66.0997% of outstanding shares)
  • Promoter & Promoter Group held 79,758,848 shares (100% voted)
  • Public Institutions held 27,054,080 shares (84.5980% voted)
  • Public Non-Institutions held 55,679,241 shares (8.5504% voted)

Resolution-wise Results:

1. Adoption of Financial Statements: 99.9629% in favor (107,360,968 votes)

2. Re-appointment of Ms. Zahabiya Khorakiwala: 91.2957% in favor (98,057,798 votes), 8.7043% against (9,349,024 votes)

3. Cost Auditor Remuneration: 99.9987% in favor (107,405,446 votes)

4. Dr. Habil Khorakiwala Remuneration Revision: 91.0250% in favor (97,767,013 votes), 8.9750% against (9,639,788 votes)

5. RPT with Wockhardt Bio AG: 97.4912% in favor (26,941,287 votes), 2.5088% against (693,285 votes)

6. RPT between Wockhardt Bio AG and CP Pharmaceuticals: 97.4912% in favor (26,941,289 votes), 2.5088% against (693,285 votes)

7. RPT between Wockhardt Bio AG and Wockhardt UK: 97.4913% in favor (26,941,299 votes), 2.5087% against (693,275 votes)

8. ₹3,000 Crore Capital Raise: 98.9533% in favor (106,282,623 votes), 1.0467% against (1,124,199 votes)

9. Ms. Zahabiya Khorakiwala Appointment at Wockhardt Bio AG: 63.0867% in favor (17,442,187 votes), 36.9133% against (10,205,787 votes)

10. Modification in QIP Objects: 99.9982% in favor (107,404,534 votes), 0.0018% against (1,960 votes)

Scrutinizer's Role and Findings

Virendra G. Bhatt, Practicing Company Secretary (ACS No.: 1157/COP No.: 124), was appointed as Scrutinizer to conduct the remote e-voting process and scrutinize the votes. The scrutinizer verified that the voting process complied with the Companies Act, 2013 and relevant rules. The report confirms that all resolutions were passed with the required majority.

Compliance Confirmation

The company confirmed compliance with applicable provisions of the Companies Act, 2013, SEBI (LODR) Regulations, 2015, and relevant MCA circulars regarding the conduct of the AGM through VC/OAVM and the voting process.